Eli Lilly seeks FDA approval for orforglipron, a once-daily pill shown in trials to help maintain weight loss after stopping ...
Arizona lawmakers are considering recognizing obesity as a chronic disease and examining the cost savings of covering ...
Investor's Business Daily on MSN
Eli Lilly, IBD stock of the day, proves the merit of its weight-loss pill
Eli Lilly proved the worth of its obesity pill Thursday. A study showed patients who switched to orforglipron mostly kept the weight off.
To Alabama football quarterback Ty Simpson, the Crimson Tide's 23-21 regular-season loss to Oklahoma was nothing different for Alabama.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results